The OPTIMA Trial: Searching For a Safer Way, w/ Didier Jutras-Aswad M.D.

The OPTIMA trial took place at 7 locations in 4 provinces across Canada and evaluated two opioid agonist treatment models of care:Methadone and Buprenorphine/Naloxone (Suboxone).When the idea for OPTIMA began, Methadone was the standard of care for people who used opioids.Suboxone was also available but not as frequently prescribed.Physicians wanted to be able to provide Suboxone based on the needs of the client and wanted to be able to do this without having the patient come into the pharmacy all the time to get itThey called it “flexible take-home dosing”Join us this week for a conversation with Principle Investigator, Didier Jutras-Aswad with the CRCHUM Research Centre in Montreal, Quebec, to learn about what they found, and our opinion on how these findings may affect people who are on Opioid Agonist Therapy.You won't want to miss this one friends, as we push to the front line of research on this special live edition,of Hard Knox Talks.Buckle up! Love what we do? Stay up to date on upcoming live streams, get on our email list, check out our shop, listen to our audios, and more. Click the link to start exploring.<br/>https://linktr.ee/hardknoxtalks